HealthQuill Myelin
Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.
Drugs Health Pharma

Contineum’s test drug may reverse multiple sclerosis damage

Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.

Read More
Researchers found a genetic variant that increases the severity of multiple sclerosis (MS) and may pave the way for a new generation of treatments to prevent disease degeneration.
Drugs Health Pharma

Gene variant discovery may trigger new treatments for multiple sclerosis

HQ Team July 5, 2023: Researchers found a genetic variant that increases the severity of multiple sclerosis (MS) and may pave the way.

Read More